- Release Date: 13/02/24 08:38
- Summary: FY24 Half Year Investor Presentation
- Price Sensitive: Yes
- Download Document 5.99MB
- Forums
- NZX - By Stock
- VSL
- Ann: FY24 Half Year Investor Presentation
Ann: FY24 Half Year Investor Presentation
Featured News
Add VSL (NZSX) to my watchlist
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online